Log in or Sign up for Free to view tailored content for your specialty!
Bone/Mineral Metabolism News
FDA clears wearable vibration belt for postmenopausal women with osteopenia
The FDA cleared a wearable vibration belt device as a non-pharmacologic treatment for postmenopausal women with osteopenia, according to an industry press release.
Vitamin D supplement does not lower fracture risk among children with 25-(OH)D deficiency
A once-weekly oral vitamin D supplementation did not reduce fracture risk over a 3-year follow-up among a group of children with vitamin D deficiency in Mongolia, according to findings published in The Lancet Diabetes & Endocrinology.
Log in or Sign up for Free to view tailored content for your specialty!
Polygenic risk score incorporating rare variants does not improve fracture prediction
The identification of rare genetic variants that influence bone mineral density did not significantly improve fracture risk screening among a large group of adults, according to data published in Journal of Bone and Mineral Research.
Long-term hormone therapy after hysterectomy yields benefits up to 20 years
Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.
Teva gains FDA approval for generic form of Forteo for certain patients with osteoporosis
Teva Pharmaceuticals announced FDA approval of a generic version of Forteo in the U.S. for certain women and men with osteoporosis, according to a company press release.
Bone density rebounds for transgender people during gender-confirming hormone therapy
Transgender people who use gender-confirming hormone therapy long term have increases in bone mineral density back to levels observed before pubertal suppression, according to findings published in JAMA Pediatrics.
Review: Menopause apps need osteoporosis content, expert insight and simplicity
Current menopause smartphone apps require more information on osteoporosis, expert input and better quality, functionality and simplicity of use and understanding for the general public, researchers reported.
Bone density decreases when stopping, never using menopausal hormone therapy
Postmenopausal women who stopped or never used hormone therapy over a 5-year period experienced a loss in bone density, whereas bone density was maintained for those who continued treatment, researchers reported in Menopause.
Fracture rates similar between adults with Graves’ disease and general population
Adults with Graves’ disease do not have an increased risk for an osteoporosis-related fracture later in life compared with those without Graves’ disease, according to data from a retrospective study published in Thyroid.
FDA expands indication for vosoritide to include children of all ages with achondroplasia
The FDA has expanded its accelerated approval of an injectable therapy for treating achondroplasia to include children of all ages, according to a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read